Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado School of Medicine, 12700 East 19th Avenue, MS C272, Aurora, CO 80045-2563, USA.
Division of Pulmonary and Critical Care Medicine, University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, Rochester, NY 14642, USA.
Immunol Allergy Clin North Am. 2020 Nov;40(4):565-573. doi: 10.1016/j.iac.2020.07.002.
Asthma-chronic obstructive pulmonary disease (COPD) overlap (ACO) defines a subgroup of patients with asthma who have persistent airflow obstruction or patients with COPD who may exhibit variable airflow limitation and/or evidence of type 2 inflammation. Additional investigations are needed to determine whether ACO represents a distinct disorder with unique underlying pathophysiology, whether ACO patients should be managed differently from those with asthma or COPD, and whether the diagnosis affects long-term outcomes. This article presents the data about the clinical features of ACO, the current information regarding the underlying pathophysiology of the syndrome, and current understanding of therapeutic options.
哮喘-慢性阻塞性肺疾病(COPD)重叠(ACO)定义了一组具有持续气流受限的哮喘患者或可能表现出可变气流受限和/或 2 型炎症证据的 COPD 患者。需要进一步研究来确定 ACO 是否代表一种具有独特潜在病理生理学的独特疾病,ACO 患者是否应与哮喘或 COPD 患者不同地管理,以及诊断是否会影响长期结果。本文介绍了 ACO 的临床特征、该综合征潜在病理生理学的现有信息以及治疗选择的现有认识。